1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as CB1 receptor modulator
    4.
    发明授权
    1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as CB1 receptor modulator 失效
    1,5-二苯基-3-吡啶基氨基-1,5-二氢吡咯烷-2-酮作为CB 1受体调节剂

    公开(公告)号:US07998985B2

    公开(公告)日:2011-08-16

    申请号:US12444692

    申请日:2007-10-22

    IPC分类号: A61K31/4439 C07D401/12

    CPC分类号: C07D401/12 C07D207/38

    摘要: Compound and pharmaceutical compositions comprising the compounds of the Formula or a pharmaceutically acceptable salt thereof, as a CB1 receptor inverse agonist, useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsychotics.

    摘要翻译: 包含下式化合物或其药学上可接受的盐作为CB1受体反向激动剂的化合物和药物组合物可用于减少哺乳动物体内的体重,治疗与精神分裂症相关的认知障碍,以及减轻用抗精神病药治疗过程中观察到的出现的体重增加 。

    1,5-DIPHENYL-3-PYRIDINYLAMINO-1,5-DIHYDROPYRROLIDIN-2-ONE AS CB1 RECEPTOR MODULATOR
    5.
    发明申请
    1,5-DIPHENYL-3-PYRIDINYLAMINO-1,5-DIHYDROPYRROLIDIN-2-ONE AS CB1 RECEPTOR MODULATOR 失效
    作为CB1受体调节剂的1,5-二苯基-3-吡啶基亚胺-1,5-二氢吡咯烷-2-酮

    公开(公告)号:US20100016375A1

    公开(公告)日:2010-01-21

    申请号:US12444692

    申请日:2007-10-22

    CPC分类号: C07D401/12 C07D207/38

    摘要: Compound and pharmaceutical compositions of Formula by blockade of the CB1 receptors via an inverse agonism mechanism, and are useful for reducing body weight in mammals, cognitive impairment associated with schizophrenia, mitigating treatment emergent weight gain observed during treatment with antipsychotics and have increased bioavailability.

    摘要翻译: 通过反向激动机制封闭CB1受体的化合物和药物组合物,并且可用于减少哺乳动物的体重,与精神分裂症相关的认知障碍,减轻在用抗精神病药治疗期间观察到的治疗紧急重量增加并且具有增加的生物利用度。